Cited by 49Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPain Management and Opioid Use

Integrated behavioral treatment for veterans with co-morbid chronic pain and hazardous opioid use: a randomized controlled pilot trial

Open access
Vowles, Kevin E., Witkiewitz, Katie, Cusack, Karen J., Gilliam, Wesley P., Cardon, Karen E., Bowen, Sarah, Edwards, Karlyn A., McEntee, Mindy L. +1 more·2020·The Journal of Pain

Abstract

Opioid prescription in the treatment of chronic pain is frequent and carries a risk of increased morbidity and mortality in a clinically significant number of patients, particularly those who are using opioids in a hazardous manner. Few treatment options are available that target both pain-related interference and hazardous opioid use among patients with chronic pain. In military Veterans, this issue is of particular importance as numerous reports indicate continued high rates of opioid prescription for chronic pain, as well as significant opioid-related problems. The overall aim of the present study was to determine the feasibility of an integrated psychosocial treatment in Veterans with chronic pain, who also have evidence of hazardous opioid use. To examine this aim, a random design was used to assess the feasibility and initial efficacy of integrating 2 empirically supported interventions: Acceptance and Commitment Therapy for chronic pain and Mindfulness Based Relapse Prevention for opioid misuse. Half of participants were randomized to the integrated treatment group and all participants received usual care through a Veteran's Administration co-occurring disorders medical clinic to treat chronic pain and opioid misuse. In total, 37 participants were randomized and included in intent-to-treat analyses and 32 individuals were included in per protocol analyses with 6-month follow-up serving as the primary study endpoint. Feasibility indicators included recruitment, retention, and treatment completion rates. Recruitment fell short of targeted enrollment, although retention and completion were excellent. Primary outcome measures were opioid misuse, pain interference, and pain behavior. Simultaneous multiple regression analyses controlled for pain duration, baseline opioid dose, and baseline value for outcome measures. Results of both the intent-to-treat and per protocol indicated a significant effect in favor of the integrated intervention for opioid misuse, pain interference, and pain behavior. Results support the feasibility of providing an integrated treatment for both opioid risk and pain interference. PERSPECTIVE: Opioid misuse occurs in some opioid-prescribed individuals with chronic pain. Few treatment options exist that target both pain interference and opioid misuse. This study examined feasibility and initial efficacy of an integrated behavioral treatment for Veterans. Feasibility was supported, except recruitment. Efficacy was supported compared to usual care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpain.2019.11.007

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Six trials evaluated an MBI, mostly among patients with OUD.

    “In total, 6 trials evaluated an MBI, mostly among pa­ tients with OUD, 24-30”

    From The Effectiveness of Interventions for Improving Chronic Pain Symptoms Among People With Mental Illness: A Systematic Review (2024) · cites this paper as [30]

    The Methods (Integrated Intervention) describe this randomized trial’s use of mindfulness-based relapse prevention, supporting its inclusion as an MBI trial. The Methods (Participants) say eligibility required opioid misuse, which could be established by a misuse score and/or an OUD diagnosis. This single trial does not establish that there were six trials or that most enrolled patients had OUD. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Of the remaining 4 SUD trials with a medium-term follow-up, a small-to-medium effect on pain reduction from baseline to medium-term follow-up was reported in all.

    “Of the remaining 4 trials with a medium-term followup, 30,39,40,45 although a small-to-medium effect on pain reduction from baseline to medium-term follow-up was reported in all, with 1 reporting a large ES, 30 one trial found this effect was only significant among women participants. 40”

    From The Effectiveness of Interventions for Improving Chronic Pain Symptoms Among People With Mental Illness: A Systematic Review (2024) · cites this paper as [30]

    The Results (Outcomes Analyses; page unavailable) report that pain interference and pain intensity decreased in the integrated-treatment group from baseline to six months. They report large effect sizes for between-group differences at follow-up (d = .79 and 1.08), however, not a small-to-medium effect size for change from baseline to follow-up. The claimed effect-size magnitude and comparison are therefore not supported for this trial. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Among the 10 SUD trials, two evaluated a CBT-based intervention, three included a MBI (one of which involved integrated MBI and ACT), two examined a MCI, one included a pharmacological-based treatment, and 2 involved a body-based intervention.

    “Two trials eval­ uated a CBT-based intervention, 20,23 three included a MBI, 27,28,30 one of which involved integrated MBI and ACT, 30 two examined a MCI, 39,40 one included a phar­ macological-based treatment, 45 and 2 involved a bodybased intervention. 35,36”
  • One of those 4 SUD trials reported a large effect size for pain reduction.

    “Of the remaining 4 trials with a medium-term followup, 30,39,40,45 although a small-to-medium effect on pain reduction from baseline to medium-term follow-up was reported in all, with 1 reporting a large ES, 30 one trial found this effect was only significant among women participants. 40”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vowles, K. E., Witkiewitz, K., Cusack, K. J., Gilliam, W. P., Cardon, K. E., Bowen, S., Edwards, K. A., McEntee, M. L., & Bailey, R. W.
Affiliations
  • Queen's University Belfast (GB)
  • University of New Mexico (US)
  • Raymond G. Murphy VA Medical Center (US)
  • Mayo Clinic (US)
  • Pacific University (US)
  • Arizona State University (US)
Corresponding author
Vowles, Kevin E.
Venue
The Journal of Pain
Publisher
Elsevier BV
Published
2020-07
Volume
21
Issue
7-8
Pages
798-807
ISSN
1526-5900 (ISSN-L)
OpenAlex
W2990418887
Cited by
49
References
64
Citations by year
2026: 4 · 2025: 6 · 2024: 13 · 2023: 8 · 2022: 7 · 2021: 7 · 2020: 4
FWCI
4.14
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion, cc-by-nc-nd)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
chronic pain, veterans, acceptance and commitment therapy, mindfulness-based relapse prevention, opioid misuse, pain interference, pain behavior, feasibility, co-occurring disorders, opioid prescribing
MeSH terms
Adult, Feasibility Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Opioid-Related Disorders, Veterans, Comorbidity, Outcome Assessment, Health Care, Chronic Pain, Mindfulness, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review